Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
NTU researchers have focused on the dual challenges faced by patients with diabetes and AKD, aiming to explore therapies that not only manage blood sugar levels but also address kidney and heart healthtwo organs critically affected by diabetes
We look to find root causes and dont stop with symptom diagnosis
Defining new criteria for selection of cell-based intestinal models using publicly available databases
GLP-1 therapy for type 2 diabetes helps improve blood sugar control, reduce insulin resistance, promote weight loss, and lower cardiovascular risk
US$ 26.06
US$ 29.65
US$ 25.03
